This is a Validated Antibody Database (VAD) review about human CDKN2C, based on 11 published articles (read how Labome selects the articles), using CDKN2C antibody in all methods. It is aimed to help Labome visitors find the most suited CDKN2C antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CDKN2C synonym: INK4C; p18; p18-INK4C

Invitrogen
mouse monoclonal (ZP001)
  • western blot; human; fig 3
In order to use transgenic mice to show that CDK5 activity is crucial for cell cycle progression and medullary thyroid carcinoma proliferation, Invitrogen CDKN2C antibody (Life Technologies, 39-3400) was used in western blot on human samples (fig 3). Oncotarget (2015) ncbi
mouse monoclonal (ZP001)
  • western blot; rat; 1:500; fig 5
In order to determine the expression of pituitary cell cycle regulators in two models of murine pituitary hyperplasia, Invitrogen CDKN2C antibody (Invitrogen, 39-3400) was used in western blot on rat samples at 1:500 (fig 5). Endocrinology (2012) ncbi
mouse monoclonal (18P118 (DCS-118))
  • immunohistochemistry - paraffin section; human; 1:20
In order to identify diagnostic and prognostic markers for glioblastoma, Invitrogen CDKN2C antibody (Lab Vision, MS-858) was used in immunohistochemistry - paraffin section on human samples at 1:20. Int J Oncol (2012) ncbi
mouse monoclonal (ZP001)
  • western blot; mouse; 1:2000
In order to determine EWS/FLI-1 function in vivo, Invitrogen CDKN2C antibody (Zymed, 39-3400) was used in western blot on mouse samples at 1:2000. Mol Cell Biol (2007) ncbi
Cell Signaling Technology
mouse monoclonal (DCS118)
  • western blot; human; 1:1000; loading ...; fig 3b
Cell Signaling Technology CDKN2C antibody (Cell Signaling Technology, 2896) was used in western blot on human samples at 1:1000 (fig 3b). Clin Transl Med (2021) ncbi
mouse monoclonal (DCS118)
  • western blot; human; loading ...; fig 2c
Cell Signaling Technology CDKN2C antibody (Cell Signaling, 2896) was used in western blot on human samples (fig 2c). J Biol Chem (2017) ncbi
mouse monoclonal (DCS118)
  • western blot; human; 1:250; loading ...; fig 1c
Cell Signaling Technology CDKN2C antibody (Cell signaling, 2896) was used in western blot on human samples at 1:250 (fig 1c). Cell Cycle (2017) ncbi
mouse monoclonal (DCS118)
  • western blot; human; 1:1000; loading ...; fig s3b
Cell Signaling Technology CDKN2C antibody (Cell Signaling, 2896) was used in western blot on human samples at 1:1000 (fig s3b). Oncogene (2017) ncbi
mouse monoclonal (DCS118)
  • western blot; human; fig 8
Cell Signaling Technology CDKN2C antibody (Cell signaling, 2896) was used in western blot on human samples (fig 8). Oncogenesis (2016) ncbi
mouse monoclonal (DCS118)
  • western blot; human; fig 7
In order to develop and characterize a protein delivery tool based on bacterial type III secretion, Cell Signaling Technology CDKN2C antibody (Cell signaling, 2896) was used in western blot on human samples (fig 7). J Cell Biol (2015) ncbi
mouse monoclonal (DCS118)
  • western blot; human
Cell Signaling Technology CDKN2C antibody (Cell Signaling Technology, 2896) was used in western blot on human samples . Int J Oncol (2015) ncbi
Articles Reviewed
  1. Sakai H, Kawakami H, Teramura T, Onodera Y, Somers E, Furuuchi K, et al. Folate receptor α increases chemotherapy resistance through stabilizing MDM2 in cooperation with PHB2 that is overcome by MORAb-202 in gastric cancer. Clin Transl Med. 2021;11:e454 pubmed publisher
  2. Juhasz A, Markel S, Gaur S, Liu H, Lu J, Jiang G, et al. NADPH oxidase 1 supports proliferation of colon cancer cells by modulating reactive oxygen species-dependent signal transduction. J Biol Chem. 2017;292:7866-7887 pubmed publisher
  3. Nuzzo A, Giuffrida D, Masturzo B, Mele P, Piccoli E, Eva C, et al. Altered expression of G1/S phase cell cycle regulators in placental mesenchymal stromal cells derived from preeclamptic pregnancies with fetal-placental compromise. Cell Cycle. 2017;16:200-212 pubmed publisher
  4. Queisser A, Hagedorn S, Wang H, Schaefer T, Konantz M, Alavi S, et al. Ecotropic viral integration site 1, a novel oncogene in prostate cancer. Oncogene. 2017;36:1573-1584 pubmed publisher
  5. Chaudhary S, Madhukrishna B, Adhya A, Keshari S, Mishra S. Overexpression of caspase 7 is ER? dependent to affect proliferation and cell growth in breast cancer cells by targeting p21(Cip). Oncogenesis. 2016;5:e219 pubmed publisher
  6. Ittig S, Schmutz C, Kasper C, Amstutz M, Schmidt A, Sauteur L, et al. A bacterial type III secretion-based protein delivery tool for broad applications in cell biology. J Cell Biol. 2015;211:913-31 pubmed publisher
  7. Pozo K, Hillmann A, Augustyn A, Plattner F, Hai T, Singh T, et al. Differential expression of cell cycle regulators in CDK5-dependent medullary thyroid carcinoma tumorigenesis. Oncotarget. 2015;6:12080-93 pubmed
  8. Wang Y, Han A, Chen E, Singh R, Chichester C, Moore R, et al. The cranberry flavonoids PAC DP-9 and quercetin aglycone induce cytotoxicity and cell cycle arrest and increase cisplatin sensitivity in ovarian cancer cells. Int J Oncol. 2015;46:1924-34 pubmed publisher
  9. Toledano Y, Zonis S, Ren S, Wawrowsky K, Chesnokova V, Melmed S. Estradiol partially recapitulates murine pituitary cell cycle response to pregnancy. Endocrinology. 2012;153:5011-22 pubmed
  10. Jung Y, Joo K, Seong D, Choi Y, Kong D, Kim Y, et al. Identification of prognostic biomarkers for glioblastomas using protein expression profiling. Int J Oncol. 2012;40:1122-32 pubmed publisher
  11. Torchia E, Boyd K, Rehg J, Qu C, Baker S. EWS/FLI-1 induces rapid onset of myeloid/erythroid leukemia in mice. Mol Cell Biol. 2007;27:7918-34 pubmed